Uncertainty-aware AI and lensfree holography enable reliable automated HER2 assessment for breast cancer diagnostics - Medical Xpress
9/10Researchers developed an AI system combined with lensfree holography to accurately and reliably assess HER2 status for breast cancer diagnostics, enhancing diagnostic precision. This innovation, reported on June 10, 2026, aims to improve breast cancer treatment decision-making.
